Cadila Healthcare informs about press release

24 May 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated May 24, 2021 titled ‘Zydus launches Ujvira (Trastuzumab Emtansine), a breakthrough in Breast Cancer treatment’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

919.90 -4.45 (-0.48%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×